Latest Breaking News On - Diamedica therapeutics company profile - Page 1 : comparemela.com

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Craig hallumDiamedica therapeutics company profileDiamedica therapeutics incDiamedica therapeuticsGet free reportMedica therapeuticsMedica therapeutics incDiamedica therapeutics daily

DiaMedica Therapeutics (NASDAQ:DMAC) Stock Price Down 8 6%

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) shares fell 8.6% on Monday . The company traded as low as $2.50 and last traded at $2.56. 183,312 shares changed hands during trading, an increase of 113% from the average session volume of 85,998 shares. The stock had previously closed at $2.80. Wall Street Analyst Weigh […]

Diamedica therapeutics company profileRenaissance technologiesCitadel advisorsDimensional fund advisorsDiamedica therapeutics incDiamedica therapeuticsGet free reportMedica therapeuticsFund advisorsStreet corpJane street groupStreet groupMedica therapeutics incDiamedica therapeutics dailyNasdaq dmac

Insider Buying: DiaMedica Therapeutics Inc (NASDAQ:DMAC) Major Shareholder Acquires $4,999,999 20 in Stock

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) major shareholder Koch Thomas Von bought 1,470,588 shares of DiaMedica Therapeutics stock in a transaction on Friday, June 23rd. The shares were acquired at an average price of $3.40 per share, for a total transaction of $4,999,999.20. Following the completion of the acquisition, the insider now owns 4,326,435 […]

Diamedica therapeutics incSecurities exchange commissionCitadel advisorsCatalyst financial partnersRenaissance technologiesDiamedica therapeutics company profileDiamedica therapeuticsFree reportKoch thomas vonExchange commissionMedica therapeuticsFinancial partnersStreet groupState street corpStreet corpMedica therapeutics inc

DiaMedica Therapeutics Inc (NASDAQ:DMAC) Director Purchases $254,150 00 in Stock

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) Director Randall Michael Giuffre acquired 65,000 shares of DiaMedica Therapeutics stock in a transaction that occurred on Friday, June 23rd. The shares were bought at an average price of $3.91 per share, with a total value of $254,150.00. Following the transaction, the director now directly owns 360,355 shares […]

Randall michael giuffreDiamedica therapeutics company profileRenaissance technologiesDimensional fund advisorsCatalyst financial partnersDiamedica therapeutics incCitadel advisorsDiamedica therapeuticsGet ratingDirector randall michael giuffreMedica therapeuticsStreet groupFinancial partnersFund advisorsMedica therapeutics incDiamedica therapeutics daily

Insider Buying: DiaMedica Therapeutics Inc (NASDAQ:DMAC) Insider Buys 38,364 Shares of Stock

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) insider David J. Wambeke purchased 38,364 shares of the stock in a transaction on Friday, June 23rd. The stock was acquired at an average cost of $3.91 per share, with a total value of $150,003.24. Following the acquisition, the insider now owns 507,114 shares of the company’s stock, […]

Davidj wambekeDiamedica therapeutics company profileRenaissance technologiesSecurities exchange commissionDiamedica therapeutics incDimensional fund advisorsCitadel advisorsDiamedica therapeuticsGet ratingExchange commissionMedica therapeuticsFund advisorsStreet corpJane street groupStreet groupMedica therapeutics inc